462 related articles for article (PubMed ID: 19567117)
1. [Expression of mucin-l and beta-catenin in papillary thyroid carcinoma and the clinical significance thereof].
He F; Li H; Li WS; Dong XH
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(6):393-6. PubMed ID: 19567117
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of the MUC1 and MUC4 expressions in thyroid papillary carcinoma.
Baek SK; Woo JS; Kwon SY; Lee SH; Chae YS; Jung KY
Laryngoscope; 2007 May; 117(5):911-6. PubMed ID: 17473695
[TBL] [Abstract][Full Text] [Related]
3. [Expression and significance of VEGF, VEGF-C, and VEGF-D in papillary thyroid carcinoma].
Jiang HG; Gao M; Tang WP; Li FH; Cai QZ
Ai Zheng; 2005 Sep; 24(9):1136-9. PubMed ID: 16159441
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of vascular endothelial growth factor C in papillary thyroid carcinoma correlates with cervical lymph node metastases.
Yu XM; Lo CY; Chan WF; Lam KY; Leung P; Luk JM
Clin Cancer Res; 2005 Nov; 11(22):8063-9. PubMed ID: 16299237
[TBL] [Abstract][Full Text] [Related]
5. [Expression and clinical significance of Mucin and E-cadherin in colorectal tumors].
Yu XW; Rong W; Xu FL; Xu GY; Sun YR; Feng MY
Ai Zheng; 2007 Nov; 26(11):1204-10. PubMed ID: 17991319
[TBL] [Abstract][Full Text] [Related]
6. Expression of cell-cycle regulators (cyclin D1, cyclin E, p27kip1, p57kip2) in papillary thyroid carcinoma.
Lee SH; Lee JK; Jin SM; Lee KC; Sohn JH; Chae SW; Kim DH
Otolaryngol Head Neck Surg; 2010 Mar; 142(3):332-7. PubMed ID: 20172376
[TBL] [Abstract][Full Text] [Related]
7. Cyclin D1 overexpression in thyroid papillary microcarcinoma: its association with tumour size and aberrant beta-catenin expression.
Lantsov D; Meirmanov S; Nakashima M; Kondo H; Saenko V; Naruke Y; Namba H; Ito M; Abrosimov A; Lushnikov E; Sekine I; Yamashita Sh
Histopathology; 2005 Sep; 47(3):248-56. PubMed ID: 16115225
[TBL] [Abstract][Full Text] [Related]
8. [Expression of mucin MUC1 and MUC2 in colorectal carcinoma and their clinical significance].
Huang WB; Shi LH; Zhu XQ; Xu GX; Qi Q
Ai Zheng; 2002 Nov; 21(11):1231-4. PubMed ID: 12526222
[TBL] [Abstract][Full Text] [Related]
9. [Clinical significance of expression of VEGF and bFGF in thyroid carcinoma].
Tian XF; Zhang XW; Chen RX; Wang JW; Zhang D
Zhonghua Wai Ke Za Zhi; 2004 Jul; 42(14):864-6. PubMed ID: 15363277
[TBL] [Abstract][Full Text] [Related]
10. [Clinical and pathological analysis of central compartment dissection in patients with papillary thyroid cancer with negative clinical lymph node metastasis].
Fu JY; Wu Y; Wang ZY; An Y; Sun TQ; Xiang J
Zhonghua Wai Ke Za Zhi; 2007 Apr; 45(7):470-2. PubMed ID: 17686305
[TBL] [Abstract][Full Text] [Related]
11. [Expression and clinical significance of Muc1, p63 protein in diffuse sclerosing variant of papillary thyroid carcinoma and conventional papillary thyroid carcinoma].
Hao Y; Jin C; Wang J
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 May; 27(9):457-61. PubMed ID: 23898609
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of FHIT, CTNNB1, and MUC1 expression in non-small cell lung cancer.
Woenckhaus M; Merk J; Stoehr R; Schaeper F; Gaumann A; Wiebe K; Hartmann A; Hofstaedter F; Dietmaier W
Hum Pathol; 2008 Jan; 39(1):126-36. PubMed ID: 17949785
[TBL] [Abstract][Full Text] [Related]
13. Association of nuclear, cytoplasmic expression of galectin-3 with beta-catenin/Wnt-pathway activation in thyroid carcinoma.
Weinberger PM; Adam BL; Gourin CG; Moretz WH; Bollag RJ; Wang BY; Liu Z; Lee JR; Terris DJ
Arch Otolaryngol Head Neck Surg; 2007 May; 133(5):503-10. PubMed ID: 17515507
[TBL] [Abstract][Full Text] [Related]
14. The Wnt/β-catenin pathway drives increased cyclin D1 levels in lymph node metastasis in papillary thyroid cancer.
Zhang J; Gill AJ; Issacs JD; Atmore B; Johns A; Delbridge LW; Lai R; McMullen TP
Hum Pathol; 2012 Jul; 43(7):1044-50. PubMed ID: 22204713
[TBL] [Abstract][Full Text] [Related]
15. Relation among p130Cas, E-cadherin and beta-catenin expression, clinicopathologic significance and prognosis in human hepatocellular carcinoma.
Guo C; Liu QG; Yang W; Zhang ZL; Yao YM
Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):490-6. PubMed ID: 18842495
[TBL] [Abstract][Full Text] [Related]
16. CXCR4 expression in papillary thyroid carcinoma: induction by nitric oxide and correlation with lymph node metastasis.
Yasuoka H; Kodama R; Hirokawa M; Takamura Y; Miyauchi A; Sanke T; Nakamura Y
BMC Cancer; 2008 Sep; 8():274. PubMed ID: 18826577
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator activated receptor gamma immunohistochemical expression in human papillary thyroid carcinoma tissues. Possible relationship to lymph node metastasis.
Galusca B; Dumollard JM; Chambonniere ML; Germain N; Prades JM; Péoc'h M; Estour B
Anticancer Res; 2004; 24(3b):1993-7. PubMed ID: 15274390
[TBL] [Abstract][Full Text] [Related]
18. [Expression and significance of APC, beta-catenin, C-myc, and Cyclin D1 proteins in colorectal carcinoma].
Dai WB; Ren ZP; Chen WL; DU J; Shi Z; Tang DY
Ai Zheng; 2007 Sep; 26(9):963-6. PubMed ID: 17927853
[TBL] [Abstract][Full Text] [Related]
19. Altered chemokine receptor expression in papillary thyroid cancer.
González HE; Leiva A; Tobar H; Böhmwald K; Tapia G; Torres J; Mosso LM; Bueno SM; Gonzalez P; Kalergis AM; Riedel CA
Thyroid; 2009 Sep; 19(9):957-65. PubMed ID: 19731977
[TBL] [Abstract][Full Text] [Related]
20. Expression of {beta}-catenin, MUC1 and c-met in diffuse-type gastric carcinomas: correlations with tumour progression and prognosis.
Retterspitz MF; Mönig SP; Schreckenberg S; Schneider PM; Hölscher AH; Dienes HP; Baldus SE
Anticancer Res; 2010 Nov; 30(11):4635-41. PubMed ID: 21115917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
